Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7637)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Capitanio S, Marini C, Sambuceti G, Morbelli S. Metformin and cancer: Technical and clinical implications for FDG-PET imaging. World J Radiol 2015; 7(3): 57-60 [PMID: 25825634 DOI: 10.4329/wjr.v7.i3.57] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v7/i3/57.htm |
| Number | Citing Articles |
| 1 |
Esha Kothekar, William Y. Raynor, Abdullah Al-Zaghal, Venkata S. Jonnakuti, Thomas J. Werner, Abass Alavi. Evolving Role of PET/CT-MRI in Assessing Muscle Disorders. PET Clinics 2019; 14(1): 71 doi: 10.1016/j.cpet.2018.08.010
|
| 2 |
Laura J. McCreight, Clifford J. Bailey, Ewan R. Pearson. Metformin and the gastrointestinal tract. Diabetologia 2016; 59(3): 426 doi: 10.1007/s00125-015-3844-9
|
| 3 |
Steve Y. Cho. To Hold or Not to Hold Metformin for FDG PET Scans: That Is the Question. Radiology 2018; 289(2): 426 doi: 10.1148/radiol.2018181566
|
| 4 |
L. Van De Voorde, L. Janssen, R. Larue, R. Houben, J. Buijsen, M. Sosef, B. Vanneste, M.-C. Schraepen, M. Berbée, P. Lambin. Can metformin improve ‘the tomorrow’ of patients treated for oesophageal cancer?. European Journal of Surgical Oncology (EJSO) 2015; 41(10): 1333 doi: 10.1016/j.ejso.2015.05.012
|
| 5 |
Michael Morris, Babak Saboury, Wengen Chen, Eliot L. Siegel, Bahar Dasgeb. Finding the sweet spot for metformin in 18F-FDG-PET. Nuclear Medicine Communications 2017; 38(10): 875 doi: 10.1097/MNM.0000000000000728
|
| 6 |
Ben Boursi, Thomas J. Werner, Saeid Gholami, Sina Houshmand, Ronac Mamtani, James D. Lewis, Gary D. Wu, Abass Alavi, Yu-Xiao Yang, François Blachier. Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT. PLOS ONE 2018; 13(2): e0192747 doi: 10.1371/journal.pone.0192747
|
| 7 |
Haiyun Qi, Per M. Nielsen, Marie Schroeder, Lotte B. Bertelsen, Fredrik Palm, Christoffer Laustsen. Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats. Diabetologia 2018; 61(2): 445 doi: 10.1007/s00125-017-4445-6
|
| 8 |
Silvia Morbelli, Maria Lucia Calcagni, Angelina Cistaro, Mohsen Farsad, Luca Guerra, Cristina Nanni, Andrea Bianchi. The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC). Clinical and Translational Imaging 2020; 8(1): 29 doi: 10.1007/s40336-019-00354-z
|
| 9 |
S. Verma, S. Chitikela, V. Singh, S. Khurana, D. Pushpam, D. Jain, S. Kumar, Y. Gupta, P. S. Malik. A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG). Medical Oncology 2023; 40(7) doi: 10.1007/s12032-023-02057-y
|